Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET/MRI and CA 19–9

Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET/MRI and CA 19–9

Abstract Background CT prediction of resectability and prognosis following neoadjuvant treatment (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) remains challenging. This study aims to determine whether addition of 18F-fluorodeoxyglucose (FDG) postiron emission tomography (PET)/MRI an...

Full description

Bibliographic Details
Main Authors: Jeongin Yoo, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Jeong Hee Yoon, Mi Hye Yu, Jin-Young Jang, Sang Hyub Lee
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Cancer Imaging
Subjects:
Pancreatic cancer
Neoadjuvant therapy
Computed tomography
Postiron emission tomography/magnetic resonance imaging
Carbohydrate antigen 19–9
Resectability
Online Access:https://doi.org/10.1186/s40644-023-00565-8

Internet

https://doi.org/10.1186/s40644-023-00565-8

Similar Items